Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2018

01-08-2018 | Case Report

Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases

Authors: Satoru Kondo, Toshimitsu Araki, Yoshiki Okita, Akira Yamamoto, Yasuhiko Hamada, Masaki Katsurahara, Noriyuki Horiki, Misaki Nakamura, Takahiro Shimoyama, Takayuki Yamamoto, Yoshiyuki Takei, Masato Kusunoki

Published in: Clinical Journal of Gastroenterology | Issue 4/2018

Login to get access

Abstract

Orally administered Qing-dai, called indigo naturalis in Latin, is reportedly useful for the treatment of ulcerative colitis. We herein describe two patients with ulcerative colitis who developed colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai. In Case 1, a 35-year-old man developed colitis similar to ischemic colitis with bloody stool that recurred each time he ingested Qing-dai. He had no signs of recurrence upon withdrawal of Qing-dai. In Case 2, a 43-year-old woman underwent ileocecal resection for treatment of an intussusception 2 months after beginning oral administration of Qing-dai. Edema and congestion but no ulceration were present in the mucosa of the resected specimen. Both patients exhibited abdominal pain with bloody diarrhea, and abdominal computed tomography showed marked wall edema affecting an extensive portion of the large bowel.
Literature
1.
go back to reference Plitzko I, Mohn T, Sedlacek N, et al. Composition of Indigo naturalis. Planta Med. 2009;75:860–3.CrossRefPubMed Plitzko I, Mohn T, Sedlacek N, et al. Composition of Indigo naturalis. Planta Med. 2009;75:860–3.CrossRefPubMed
2.
go back to reference Deng S, May BH, Zhang AL, et al. Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169:769–82.CrossRefPubMed Deng S, May BH, Zhang AL, et al. Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169:769–82.CrossRefPubMed
3.
go back to reference Lin YK, Chang CJ, Chang YC, et al. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol. 2008;144:1457–64.CrossRefPubMed Lin YK, Chang CJ, Chang YC, et al. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol. 2008;144:1457–64.CrossRefPubMed
4.
go back to reference Zhang F, Li Y, Xu F, et al. Comparison of Xilei-san, a Chinese herbal medicine, and dexamethasone in mild/moderate ulcerative proctitis: a double-blind randomized clinical trial. J Altern Complement Med. 2013;19:838–42.CrossRefPubMed Zhang F, Li Y, Xu F, et al. Comparison of Xilei-san, a Chinese herbal medicine, and dexamethasone in mild/moderate ulcerative proctitis: a double-blind randomized clinical trial. J Altern Complement Med. 2013;19:838–42.CrossRefPubMed
5.
go back to reference Fukunaga K, Ohda Y, Hida N, et al. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. J Gastroenterol Hepatol. 2012;27:1808–15.CrossRefPubMed Fukunaga K, Ohda Y, Hida N, et al. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. J Gastroenterol Hepatol. 2012;27:1808–15.CrossRefPubMed
6.
go back to reference Suzuki H, Kaneko T, Mizokami Y, et al. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol. 2013;19:2718–22.CrossRefPubMedPubMedCentral Suzuki H, Kaneko T, Mizokami Y, et al. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol. 2013;19:2718–22.CrossRefPubMedPubMedCentral
7.
go back to reference Sugimoto S, Naganuma M, Kiyohara H, et al. Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: a single-center open-label prospective study. Digestion. 2016;93:193–201.CrossRefPubMed Sugimoto S, Naganuma M, Kiyohara H, et al. Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: a single-center open-label prospective study. Digestion. 2016;93:193–201.CrossRefPubMed
8.
go back to reference Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol. 2016;51:853–61.CrossRefPubMed Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol. 2016;51:853–61.CrossRefPubMed
9.
go back to reference Suo BJ, Zhou LY, Ding SG. et al [The endoscopic and clinical features of Indigo Naturalis-associated ischemic lesions of colonic mucosa]. Zhonghua Nei Ke Za Zhi. 2011;50:646–9.PubMed Suo BJ, Zhou LY, Ding SG. et al [The endoscopic and clinical features of Indigo Naturalis-associated ischemic lesions of colonic mucosa]. Zhonghua Nei Ke Za Zhi. 2011;50:646–9.PubMed
10.
go back to reference Xiao HT, Peng J, Hu DD, et al. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice. Chin Med. 2015;10:29.CrossRefPubMedPubMedCentral Xiao HT, Peng J, Hu DD, et al. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice. Chin Med. 2015;10:29.CrossRefPubMedPubMedCentral
11.
go back to reference Sugihara K, Okayama T, Kitamura S, et al. Comparative study of aryl hydrocarbon receptor ligand activities of six chemicals in vitro and in vivo. Arch Toxicol. 2008;82:5–11.CrossRefPubMed Sugihara K, Okayama T, Kitamura S, et al. Comparative study of aryl hydrocarbon receptor ligand activities of six chemicals in vitro and in vivo. Arch Toxicol. 2008;82:5–11.CrossRefPubMed
12.
go back to reference Adachi J, Mori Y, Matsui S, et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem. 2001;276:31475–8.CrossRefPubMed Adachi J, Mori Y, Matsui S, et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem. 2001;276:31475–8.CrossRefPubMed
13.
go back to reference Kawai S, Iijima H, Shinzaki S, et al. Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol. 2017;52:904–19.CrossRefPubMed Kawai S, Iijima H, Shinzaki S, et al. Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol. 2017;52:904–19.CrossRefPubMed
14.
go back to reference Qiu J, Guo X, Chen ZM, et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity. 2013;39:386–99.CrossRefPubMed Qiu J, Guo X, Chen ZM, et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity. 2013;39:386–99.CrossRefPubMed
15.
go back to reference Liu JZ, Pezeshki M, Raffatellu M. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. Cytokine. 2009;48:156–60.CrossRefPubMedPubMedCentral Liu JZ, Pezeshki M, Raffatellu M. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. Cytokine. 2009;48:156–60.CrossRefPubMedPubMedCentral
16.
go back to reference Yu IS, Lee JS, Kim SD, et al. Monitoring heavy metals, residual agricultural chemicals and sulfites in traditional herbal decoctions. BMC Complement Altern Med. 2017;17:154.CrossRefPubMedPubMedCentral Yu IS, Lee JS, Kim SD, et al. Monitoring heavy metals, residual agricultural chemicals and sulfites in traditional herbal decoctions. BMC Complement Altern Med. 2017;17:154.CrossRefPubMedPubMedCentral
17.
go back to reference Fong HH. Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther. 2002;1:287–93.CrossRefPubMed Fong HH. Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther. 2002;1:287–93.CrossRefPubMed
18.
go back to reference Zhang J, Wider B, Shang H, et al. Quality of herbal medicines: challenges and solutions. Complement Ther Med. 2012;20:100–6.CrossRefPubMed Zhang J, Wider B, Shang H, et al. Quality of herbal medicines: challenges and solutions. Complement Ther Med. 2012;20:100–6.CrossRefPubMed
19.
go back to reference WHO: World Health Organization guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: World Health Organization; 2007. WHO: World Health Organization guidelines for assessing quality of herbal medicines with reference to contaminants and residues. Geneva: World Health Organization; 2007.
Metadata
Title
Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases
Authors
Satoru Kondo
Toshimitsu Araki
Yoshiki Okita
Akira Yamamoto
Yasuhiko Hamada
Masaki Katsurahara
Noriyuki Horiki
Misaki Nakamura
Takahiro Shimoyama
Takayuki Yamamoto
Yoshiyuki Takei
Masato Kusunoki
Publication date
01-08-2018
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2018
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0851-7

Other articles of this Issue 4/2018

Clinical Journal of Gastroenterology 4/2018 Go to the issue